College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants.
about
Emerging critical role of molecular testing in diagnostic genitourinary pathologyMultiple factors influence compliance with colorectal cancer staging recommendations: an exploratory study.ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.Clinicopathological study of male breast carcinoma: 24 years of experience.Importance of metastatic lymph node ratio in non-metastatic, lymph node-invaded colon cancer: a clinical trial.Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies.Osteosarcoma microenvironment: whole-slide imaging and optimized antigen detection overcome major limitations in immunohistochemical quantification.Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach.The size of retrieved lymph nodes correlates with the number of retrieved lymph nodes and is an independent prognostic factor in patients with stage II colon cancer.Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.Validation of biomarker-based risk prediction modelsLymph node evaluation as a colon cancer quality measure: a national hospital report card.Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance.Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.
P2860
Q27021371-9EAE4B6F-6701-467C-85C3-49BE72E04C12Q30481526-7FB0B618-9226-49CF-BA32-2055C86FB801Q33346972-9F51A37A-0E1C-4C11-A53B-1C44D4762B92Q33738278-40287DC8-946E-413E-8B63-B9490F3C6CAAQ34062146-D7FED492-75AD-42F6-86A3-6015C35417AEQ34234728-B69E5104-36E7-44FE-9443-E434AC65A5C7Q35110990-0D6CB628-5C32-42BB-9C93-1B2E3AC1E3CDQ35537640-66F1D553-1B8A-4ED7-A9E0-446ABEE5665CQ36363314-21F6BA2B-163B-49C3-A7D6-90B7150D03EEQ36643900-7258ACE4-BAA5-4A41-9C2F-E333AC610A3DQ37076532-183CB235-7F20-4515-87D0-E4A1E532E584Q37284258-03B13B24-F78B-4C63-A19C-C273D9173520Q37288920-11414C67-43A6-44C7-AA1D-3465FF682847Q37305442-DF423AD3-297B-43A5-BC02-8E4786028540Q50484680-837762DE-DFF9-4FDE-998F-054ADEBEFB6D
P2860
College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
College of American Pathologis ...... e and Conference Participants.
@ast
College of American Pathologis ...... e and Conference Participants.
@en
type
label
College of American Pathologis ...... e and Conference Participants.
@ast
College of American Pathologis ...... e and Conference Participants.
@en
prefLabel
College of American Pathologis ...... e and Conference Participants.
@ast
College of American Pathologis ...... e and Conference Participants.
@en
P2093
P1476
College of American Pathologis ...... e and Conference Participants.
@en
P2093
Bostwick D
Compton CC
Fielding LP
Fitzgibbons PL
Grignon DJ
Hammond ME
P304
P356
10.1043/0003-9985(2000)124<0958:COAPCX>2.0.CO;2
P577
2000-07-01T00:00:00Z